Journal of Liver: Disease & TransplantationISSN: 2325-9612

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Targeting Immune Checkpoint Proteins as Novel Strategy for Treatment of Hepatocellular Carcinoma

In recent years, cancer immunotherapy has been a recent hot topic among scientists over the world. So far, the discovered checkpoint protein molecules include cytotoxic T lymphocyte antigen-4 (CTLA-4), programmed death-1 (PD-1), lymphocyte activation gene-3 (LAG-3) and several others. The overexpression of the checkpoint proteins could lead the decreased T-cell cytotoxicity, proliferation and cytokine production.

Special Features

Full Text

View

Track Your Manuscript

Share This Page

Media Partners

Associations